MX352326B - Tableta resistente al alcohol. - Google Patents
Tableta resistente al alcohol.Info
- Publication number
- MX352326B MX352326B MX2011003562A MX2011003562A MX352326B MX 352326 B MX352326 B MX 352326B MX 2011003562 A MX2011003562 A MX 2011003562A MX 2011003562 A MX2011003562 A MX 2011003562A MX 352326 B MX352326 B MX 352326B
- Authority
- MX
- Mexico
- Prior art keywords
- microgranules
- oral pharmaceutical
- pharmaceutical form
- alcohol
- release oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a una forma farmacéutica oral que contiene microgránulos para la liberación sostenida de por lo menos un principio activo, incluyendo un vehículo neutro que es insoluble en agua o en una solución alcohólica, o un vehículo neutro que se ha hecho insoluble en agua o una solución de alcohol, que comprende por lo menos una primera capa de montaje que contiene por lo menos un principio activo y opcionalmente un agente aglutinante farmacéuticamente aceptable, en donde el ensamble comprende por lo menos un revestimiento que contiene por lo menos un polímero hidrofóbico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0856660A FR2936709B1 (fr) | 2008-10-02 | 2008-10-02 | Comprimes alcoolo-resistants. |
PCT/EP2009/062836 WO2010037854A2 (fr) | 2008-10-02 | 2009-10-02 | Comprimés alcoolo-résistants |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2011003562A MX2011003562A (es) | 2011-05-02 |
MX352326B true MX352326B (es) | 2017-11-17 |
Family
ID=40547402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011003562A MX352326B (es) | 2008-10-02 | 2009-10-02 | Tableta resistente al alcohol. |
Country Status (13)
Country | Link |
---|---|
US (1) | US9492397B2 (es) |
EP (1) | EP2349227B1 (es) |
JP (1) | JP2012504582A (es) |
KR (1) | KR101632368B1 (es) |
CN (1) | CN102215827B (es) |
AU (1) | AU2009299810B2 (es) |
BR (1) | BRPI0913822B1 (es) |
CA (1) | CA2739018C (es) |
ES (1) | ES2683096T3 (es) |
FR (1) | FR2936709B1 (es) |
IL (1) | IL212008A (es) |
MX (1) | MX352326B (es) |
WO (1) | WO2010037854A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
BR112012001244A2 (pt) | 2009-07-22 | 2020-12-08 | Gruünenthal Gmbh | Forma de dosagem resitente à adulteração, seu processo de produção, e embalagem contendo tal forma |
US9877925B2 (en) | 2010-05-14 | 2018-01-30 | Ethypharm | Alcohol-resistant oral pharmaceutical form |
US20130059010A1 (en) * | 2010-05-14 | 2013-03-07 | Ethypharm | Alcohol-resistant oral pharmaceutical form |
RU2604676C2 (ru) | 2010-09-02 | 2016-12-10 | Грюненталь Гмбх | Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль |
BR112014002022A2 (pt) | 2011-07-29 | 2017-02-21 | Gruenenthal Gmbh | comprimido resistente à violação proporcionando liberação de fármaco imediata |
PT2736497T (pt) | 2011-07-29 | 2017-11-30 | Gruenenthal Gmbh | Comprimido resistente a adulteração proporcionando libertação imediata de fármaco |
ES2692944T3 (es) | 2012-04-18 | 2018-12-05 | Grünenthal GmbH | Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis |
US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
CN105934241B (zh) | 2013-11-26 | 2020-06-05 | 格吕伦塔尔有限公司 | 通过低温研磨制备粉末状药物组合物 |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
CN109922801B (zh) * | 2016-09-09 | 2023-07-18 | 库蒂斯制药公司 | 甲硝唑和巴氯芬的混悬剂和稀释剂 |
ES2963929T3 (es) | 2017-05-29 | 2024-04-03 | Gruenenthal Gmbh | Forma farmacéutica oral multipartículas que proporciona liberación prolongada de tapentadol |
GR1009751B (el) | 2019-03-22 | 2020-05-29 | "Φαρματεν Α.Β.Ε.Ε." | Σκευασμα παρατεταμενης αποδεσμευσης που περιλαμβανει οξαλικη ταπενταδολη και μεθοδος παρασκευης αυτου |
CN115666546A (zh) | 2020-04-03 | 2023-01-31 | 卢普奥克西治疗公司 | 肠内有氧化疗法 |
KR20240095216A (ko) * | 2021-09-29 | 2024-06-25 | 엘폭시 세라퓨틱스 인코퍼레이티드 | 장 호기화 요법 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143037A (en) * | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
JP2004518734A (ja) * | 2000-10-24 | 2004-06-24 | スミスクライン・ビーチャム・コーポレイション | カルベジロールの新規処方 |
US6902637B2 (en) * | 2001-01-23 | 2005-06-07 | Trw Inc. | Process for preparing free-flowing particulate phase stabilized ammonium nitrate |
CA2447693A1 (en) * | 2001-05-31 | 2002-12-05 | Cima Labs Inc. | Taste-masking of highly water-soluble drugs |
FR2842736B1 (fr) * | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
EP1802285B1 (en) * | 2004-10-21 | 2013-02-27 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
FR2881652B1 (fr) * | 2005-02-08 | 2007-05-25 | Flamel Technologies Sa | Forme pharmaceutique orale microparticulaire anti-mesuage |
AU2006259619A1 (en) * | 2005-06-16 | 2006-12-28 | Forest Laboratories, Inc. | Modified and immediate release memantine bead formulation |
US20070092568A1 (en) * | 2005-10-10 | 2007-04-26 | Gore Subhash P | Galantamine compositions |
ES2533563T5 (es) * | 2006-01-27 | 2018-07-24 | Adare Pharmaceuticals, Inc. | Sistemas de suministro de fármacos que comprenden fármacos débilmente básicos y ácidos orgánicos |
DE102006006785B4 (de) * | 2006-02-14 | 2008-07-03 | BSH Bosch und Siemens Hausgeräte GmbH | Heizsystem mit Rückführung |
FR2897267A1 (fr) * | 2006-02-16 | 2007-08-17 | Flamel Technologies Sa | Formes pharmaceutiques multimicroparticulaires pour administration per os |
ATE536864T1 (de) * | 2006-02-24 | 2011-12-15 | Teva Pharma | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung |
JP2009530397A (ja) * | 2006-03-21 | 2009-08-27 | テバ ファーマシューティカル インダストリーズ リミティド | トルテロジンの調節された開放性製剤 |
US8158156B2 (en) | 2006-06-19 | 2012-04-17 | Alpharma Pharmaceuticals, Llc | Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist |
US20080003286A1 (en) * | 2006-06-29 | 2008-01-03 | Sathya Narayana Vemula | Sustained delivery alfuzosin compositions |
-
2008
- 2008-10-02 FR FR0856660A patent/FR2936709B1/fr active Active
-
2009
- 2009-10-02 ES ES09783697.7T patent/ES2683096T3/es active Active
- 2009-10-02 KR KR1020117010114A patent/KR101632368B1/ko active IP Right Grant
- 2009-10-02 JP JP2011529569A patent/JP2012504582A/ja active Pending
- 2009-10-02 WO PCT/EP2009/062836 patent/WO2010037854A2/fr active Application Filing
- 2009-10-02 CN CN200980139219.7A patent/CN102215827B/zh active Active
- 2009-10-02 MX MX2011003562A patent/MX352326B/es active IP Right Grant
- 2009-10-02 CA CA2739018A patent/CA2739018C/fr active Active
- 2009-10-02 BR BRPI0913822A patent/BRPI0913822B1/pt active IP Right Grant
- 2009-10-02 EP EP09783697.7A patent/EP2349227B1/fr active Active
- 2009-10-02 AU AU2009299810A patent/AU2009299810B2/en active Active
- 2009-10-02 US US13/122,261 patent/US9492397B2/en active Active
-
2011
- 2011-03-29 IL IL212008A patent/IL212008A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN102215827B (zh) | 2016-10-05 |
WO2010037854A3 (fr) | 2010-12-23 |
US20110177138A1 (en) | 2011-07-21 |
MX2011003562A (es) | 2011-05-02 |
US9492397B2 (en) | 2016-11-15 |
EP2349227B1 (fr) | 2018-05-30 |
CN102215827A (zh) | 2011-10-12 |
FR2936709A1 (fr) | 2010-04-09 |
CA2739018C (fr) | 2017-02-28 |
JP2012504582A (ja) | 2012-02-23 |
KR101632368B1 (ko) | 2016-06-21 |
CA2739018A1 (fr) | 2010-04-08 |
FR2936709B1 (fr) | 2012-05-11 |
AU2009299810B2 (en) | 2014-08-14 |
BRPI0913822B1 (pt) | 2018-12-26 |
BRPI0913822A2 (pt) | 2015-10-20 |
IL212008A (en) | 2016-06-30 |
AU2009299810A1 (en) | 2010-04-08 |
WO2010037854A2 (fr) | 2010-04-08 |
EP2349227A2 (fr) | 2011-08-03 |
IL212008A0 (en) | 2011-06-30 |
ES2683096T3 (es) | 2018-09-25 |
KR20110070889A (ko) | 2011-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX352326B (es) | Tableta resistente al alcohol. | |
WO2007135193A3 (fr) | Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool | |
WO2006084164A8 (en) | Gastric retention and controlled release delivery system | |
WO2009059701A3 (de) | Retardtabletten mit hydromorphon | |
HK1132175A1 (en) | Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity | |
IL245290A0 (en) | A medical system for introducing the active substance buprenorphine through the skin | |
PL1834635T3 (pl) | Stabilne układy nanokapsułek do podawania cząsteczek aktywnych | |
MY173730A (en) | Orally-disintegrating solid preparation | |
EP1973952A4 (en) | CONJUGATE COMPRISING A COVALENT TO A MUCOADHESIVE POLYMER-ASSOCIATED PHARMACEUTICALLY ACTIVE COMPOUND, AND A TRANSMUCOSAL ADMINISTRATION METHOD FOR A PHARMACEUTICALLY ACTIVE COMPOUND USING THEREOF | |
WO2007085629A3 (en) | Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents | |
WO2010015567A3 (en) | Controlled release formulations using intelligent polymers | |
WO2009063222A3 (en) | Solid compositions | |
TW200833372A (en) | Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound | |
TW200738278A (en) | A liposome combination and the use thereof | |
WO2010048478A3 (en) | Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates | |
WO2012002640A3 (ko) | 도네페질을 함유하는 경피흡수제제 | |
WO2012022919A3 (fr) | Formulations à base de nalbuphine et leurs utilisations | |
WO2009031859A3 (en) | Multi-functional complex for imaging and drug delivery | |
WO2012092486A3 (en) | Modified release benzimidazole formulations | |
GB0408012D0 (en) | Delivery system for an active agent | |
WO2007110753A3 (en) | Extended release dosage forms of metoprolol | |
TWI348495B (en) | Soil releasing agent containing fluoro-containing polymer | |
WO2008035229A3 (en) | Compositions and methods for ph targeted drug delivery | |
WO2011090725A3 (en) | Gastroretentive solid oral dosage forms with swellable hydrophilic polymer | |
WO2010059563A3 (en) | Targeted drug delivery for aneurysm treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |